Did they give any updates on their pill?I spoke to these guys today. They said it will be one or two years before the injectable drug starts clinical trials.
Did they give any updates on their pill?I spoke to these guys today. They said it will be one or two years before the injectable drug starts clinical trials.
We should just forget about these guys - if they do produce a breakthrough we'll know about it. If not then we'll not have wasted any time. They'll be last chronologically anyway.I wish Hough Ear Institute would be more transparent. All of our suspicions could be due to simple misunderstandings. But their silence makes me worry that their drug isn't working the way they thought it would and that they're trying to cover it up.
If it wasn't for the Phase 1 extension for OTO-413, I would have. If Hough Ear Institute/Oblato manages to initiate their Phase 2 trial this year, that would actually put them ahead of Otonomy and Pipeline Therapeutics. I do wish they'd just tell us what's going on straight up.We should just forget about these guys - if they do produce a breakthrough we'll know about it. If not then we'll not have wasted any time. They'll be last chronologically anyway.
Is there any link to this research?Additionally, we just had out tinnitus research published
Electrophysiological assessment and pharmacological treatment of blast-induced tinnitus. This might be one (January 2021, so yes rather recent). Most of the authors appear in the research staff page of the Hough Ear Institute.Is there any link to this research?
I think it comes down to funding being a big part of it. However, the mechanisms and methods utilised by Hough Ear Institute to gain funding have simply been quite poor.Okay I know I am really late to the party on this one, but apparently NHPN-1010 finished its Phase 1 trial back in 2015.
How have they still not finished the Proof of Concept yet for Phase 2? It seems like they are really struggling or something, because they are really taking their time one this one.
I only listened to the interview at the end. At around 52 minutes he talks about 3-5 years where people can use it? And starting clinical trials in a couple of years? Not too sure about the wording on that one.Can someone make a TL;DR?
Would this work for acoustic trauma from years past?I only listened to the interview at the end. At around 52 minutes he talks about 3-5 years where people can use it? And starting clinical trials in a couple of years? Not too sure about the wording on that one.
He said that the Phase 2 trial for the Pill will be expensive, at around $10-20 million. The Phase 1 trial was "cheap" apparently at $1 million. They aren't sure whether the Phase 2 trial will be for noise-induced hearing loss, tinnitus or ototoxicity.
The Injection technology is apparently in the preclinical phase while the Pill is at Phase 2.
The sweet spot is at 52 minutes - 57 minutes.
Sorry if my post is confusing. I'm sleepy and it's late lol. After watching it again it appears that this is intended for Acute Acoustic Trauma (24 minutes time stamp). I wonder if it will be too late for us by the time this comes to the market.
Yes, it takes literally decades for the treatment window to close.Would this work for acoustic trauma from years past?
Can I ask for a source on this?Yes, it takes literally decades for the treatment window to close.
To explain it very quickly: Some papers showed, that NHPN-1010 increases the BDNF concentration (not sure whether studies where animal studies or on vitro). By this, synaptic growth is enhanced and hidden hearing loss hopefully treated (basically in the same way as OTO-413 intends to). As long as the hair cells and the neurons (with the missing synapses) still exist, it is possible to restore the synaptic connection between these two. It is believed that the neurons do not die for many years or even decades in humans even if they do not receive any input anymore (due to destroyed synapses). Therefore the treatment window only closes if the neurons die.Can I ask for a source on this?
FDA banned NAC as a supplement.If FDA is banning NAC, how will that affect this research?
Why would it impact this research? It appears that the FDA has issues with it being sold as a supplement, not with it being sold/used as a prescription drug.If FDA is banning NAC, how will that affect this research?
I've been wondering if there's a way to determine whether one has damaged nerves or hair cell loss or both?Hopefully Hough Ear Institute pulls through with some success. Last time I spoke with them and read their newsletter they said they think their pill can regrow nerves — providing relief from tinnitus and inflammation of the inner ear from noise exposure.
I'm not expecting anything but I feel like those of us who got noise-induced tinnitus/inflammation have more of an issue with damaged nerves than with hair cell loss, though I'm not an expert and could be wrong on that point.
Either way, I hope for the best and that we can get more updates from them.